Navigation Links
MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
Date:11/13/2007

officers and directors may, under SEC rules, be deemed to be participants in the solicitation of proxies from shareholders of the Company in connection with the upcoming annual meeting. Certain information about such individuals (including their ownership of shares of the Company's common stock) is set forth in the Company's Form 10-K for the year ended December 31, 2006, which is available free of charge from the SEC and the Company as indicated above.

About MedQuist:

MedQuist is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web- based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.

Disclosure Regarding Forward-Looking Statements:

Some of the statements in this Press Release constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are not historical facts but rather are based on the Company's current expectations, estimates and projections regarding the Company's business, operations and other factors relating thereto. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are used to identify these forward-looking statements. The forward-looking statements contained in this Press Release include, without limitation, statements about the timing of and business to be brought before an upcoming annual meeting of the shareholders of MedQuist. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict, including, without limitation, the
'/>"/>

SOURCE MedQuist Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MedQuist Re-launches New, Improved Web Site
2. MedQuist Updates Status of Outstanding SEC Filings
3. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
4. MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
5. Alvarado Hospital Files Countersuit Against Blue Shield
6. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Gentiva(R) Health Services Files Universal Shelf Registration Statement
9. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
10. CIGNA Behavioral Health Offers Members Online Provider Profiles
11. American Media Operations, Inc. Files Form 10-Q For First Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ralization ready at Passport .../ -- New vaccine requirements will affect,anyone w...o the U.S. and,anyone seeking adjustment of status...of of vaccinations against vaccine-preventable dis...ee on Immunization Practices.,Passport Health, a c...
(Date:7/23/2008)...rm count, motility, study finds , , THUR...lly invasive procedure can treat a common cause of...f having a baby, a new study finds. , The condi...lood vessels in the scrotum which prevents the nor...testicles. A minimally invasive radiological proce...
(Date:7/23/2008)...may be tough, but,Hollywood,s young stars like Lan...ing new smile to boost confidence. Cosmetic dentis...nts beam in on success, citing his,experience that...nce they,need for stardom. In agreement is Landon ...e designed by Dr. Kosdon., MTV,s Rock The Cradle ...
(Date:7/23/2008)...rouble, the worse their performance , , ...en suffering from coronary heart disease seem to f...And the longer the person had had heart disease, t...as reasoning, vocabulary and verbal fluency, accor...ean Heart Journal . , The research, however, ha...
Breaking Medicine News(10 mins):Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Coronary Disease Dulls Cognitive Skills 2
...a Corporation announced that, in conjunction with ...T), both parties have agreed for reasons of futil...) for the treatment of cystic fibrosis (CF). Genae...amine in prostate cancer, which is an investigator...
...li, daughter of Bangladeshi immigrants to the Unit...2007. Nora, 17, won the final competition, held i... than $60,000, The Daily Star said Wednesday, quot..."I just want to start a business and maybe even st...
...owth of Internet applications in healthcare has be...g increasingly involved in the healthcare service...acteristics that distinguish them from traditional...r in driving the use of the Internet in healthcare...
...en in Somerville town in Massachusetts are losing ... take notice. The kids of Somerville, a town of ...nutrition programme aimed at helping them learn he...hem throughout their lives. As a result the Somerv...
Other Medicine News:Health News:Genaera Discontinues Lomucin in Cystic Fibrosis Studies 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 3Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 2Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 3
(Date:7/22/2008)... and pegylated enzyme produces significantly en... - Pegylated enzyme well tolerated ...alozyme Therapeutics,Inc. (Nasdaq: HALO ), a bio...ing products targeting the extracellular matrix, t...inical animal efficacy data,for its pegylated-rHuP...
(Date:7/22/2008)...Approach of LASH (Laser Assisted Scar Healing)... MARSEILLES, France, July 22 /- Ekkyo...dicine company, which develops first-in-class,lase...tion, announced today,the publication of a scienti...orting the results of a pilot study on cutaneous s...
(Date:7/21/2008)... 2008 conferences, GAITHERSBURG, Md., July 21 /PR... company developing gene therapies for HIV and gen...6 Phase I and Phase II,clinical trials for the med...s an investigational gene therapy for the treatmen...rsday, July 24, 2008 at 11 a.m. EDT. The,presentat...
(Date:7/21/2008)...impedance spectroscopy (BIS) is,more accurate and ...ent of,lymphedema in breast cancer patients, accor...Journal of Clinical Oncology (2008; Vol. 26, Issue...t Cancer: Incidence, Risk Factors, and,Effect on U... Hayes, PhD.,and colleagues from Queensland Unive...
Breaking Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Into the wild 3447 1Life but not as we know it 3F 3443 1Life but not as we know it 3F 3443 2X rays often repeated for patients in developing countries 20385 1X rays often repeated for patients in developing countries 20385 2X rays often repeated for patients in developing countries 20385 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 1Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 2Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 4
...YTOWN, N.Y., June 15, 2007 /PRNewswire-FirstCall/ ... of scientific studies that,(1) demonstrate that A...ple types of human tumors in animal models, (2) re...cts, and (3) show that,MPC-6827 is not affected by...drug resistance. The study results appear in the J...
...HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ ...g how a new flu vaccine has the,potential to prote...demic and annual, was presented today by PepTcell,...VI (Options) Conference, in,Toronto, Canada. , The...the,European Journal of Immunology, showed how mic...
Other Medicine Technology:New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
...ll-natural moisturizing mist for the eyes develope...thers, from Oregon Health Sciences University's Ca...TEARS (2000) and dry eye patients showed, on avera...he eyes' tear film without disrupting the tear fil...
Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and
This latest sensor array with 275 channels gives an average inter-channel spacing of just 2.2 cm. This high-density array is particularly useful when using advanced analysis techniques, such as Synt
...ement position is achieved using an increased tilt...tient bed. The patient preparation can be carried ...ency the patient can be brought rapidly outside th...he integrated neck support increases patient safet...
Medicine Products: